Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
Autors principals: | Xue, L, Hardman, C, Chen, W, Batty, P, Ogg, G, Erpenbeck, V, Sandham, D |
---|---|
Format: | Conference item |
Publicat: |
American Thoracic Society
2018
|
Ítems similars
-
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
per: Chen, W, et al.
Publicat: (2018) -
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
per: Hardman, C, et al.
Publicat: (2019) -
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
per: Sandham, D, et al.
Publicat: (2019) -
Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
per: Xue, L, et al.
Publicat: (2019) -
Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
per: Ogg, G, et al.
Publicat: (2015)